Study design of Heart failure Events reduction withRemote Monitoring and eHealth Support (HERMeS)

Simple item page
dc.contributor.authorYun, Sergi
dc.contributor.authorEnjuanes, Cristina
dc.contributor.authorCalero, Esther
dc.contributor.authorHidalgo, Encarnación
dc.contributor.authorCobo, Marta
dc.contributor.authorLlàcer, Pau
dc.contributor.authorGarcía Pinilla, José Manuel
dc.contributor.authorGonzález Franco, Álvaro
dc.contributor.authorNúñez, Julio
dc.contributor.authorMorales Rull, José Luis
dc.contributor.authorBeltrán, Paola
dc.contributor.authorDelso, Cristina
dc.contributor.authorFreixa Pamias, Román
dc.contributor.authorMoliner, Pedro
dc.contributor.authorCorbella, Xavier
dc.contributor.authorComín Colet, Josep
dc.date.accessioned2022-05-12T12:17:48Z
dc.date.available2022-05-12T12:17:48Z
dc.date.issued2020
dc.description.abstractAims. The role of non-invasive telemedicine (TM) combining telemonitoring and teleintervention by videoconference (VC) in patients recently admitted due to heart failure (HF) (‘vulnerable phase’ HF patients) is not well established. The aim of the Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS) trial is to assess the impact on clinical outcomes of implementing a TM service based on mobile health (mHealth), which includes remote daily monitoring of biometric data and symptom reporting (telemonitoring) combined with VC structured, nurse-based follow-up (teleintervention). The results will be compared with those of the comprehensive HF usual care (UC) strategy based on face-to-face on-site visits at the vulnerable post-discharge phase. Methods and results. We designed a 24 week nationwide, multicentre, randomized, controlled, open-label, blinded endpoint adjudication trial to assess the effect on cardiovascular (CV) mortality and non-fatal HF events of a TM-based comprehensive management programme, based on mHealth, for patients with chronic HF. Approximately 508 patients with a recent hospital admission due to HF decompensation will be randomized (1:1) to either structured follow-up based on face-to-face appointments (UC group) or the delivery of health care using TM. The primary outcome will be a composite of death from CV causes or non-fatal HF events (first and recurrent) at the end of a 6 month follow-up period. Key secondary endpoints will include components of the primary event analysis, recurrent event analysis, and patient-reported outcomes. Conclusions. The HERMeS trial will assess the efficacy of a TM-based follow-up strategy for real-world ‘vulnerable phase’ HF patients combining telemonitoring and teleintervention.ca_ES
dc.identifier.doihttps://doi.org/10.1002/ehf2.12962
dc.identifier.issn2055-5822
dc.identifier.urihttp://hdl.handle.net/10459.1/83273
dc.language.isoengca_ES
dc.publisherWiley Open Accessca_ES
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1002/ehf2.12962ca_ES
dc.relation.ispartofESC Heart Failure, vol. 7, núm. 6, 4448–4457ca_ES
dc.rightscc-by-nc-nd (c) The Authors, 2020ca_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectChronic heart failureca_ES
dc.subjectTelemedicineca_ES
dc.subjectmHealthca_ES
dc.subjectOutcomes researchca_ES
dc.subjectChronic care modelca_ES
dc.subjectTransitional careca_ES
dc.titleStudy design of Heart failure Events reduction withRemote Monitoring and eHealth Support (HERMeS)ca_ES
dc.typeinfo:eu-repo/semantics/articleca_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_ES
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
escheafail_a2020-v7n6.pdf
Size:
4 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Articles publicats (Medicina i Cirurgia)
Articles publicats (IRBLleida)